RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
34.47
0.00 (-0.01%)
At close: Dec 5, 2025, 4:00 PM EST
33.82
-0.65 (-1.87%)
After-hours: Dec 5, 2025, 6:43 PM EST
RAPT Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | 1.53 | 3.81 | 5.04 | |
| Revenue Growth (YoY) | - | - | - | -59.95% | -24.38% | - | |
| Gross Profit | - | - | - | 1.53 | 3.81 | 5.04 | |
| Selling, General & Admin | 29.76 | 28.88 | 26.06 | 20.24 | 16.04 | 12.77 | |
| Research & Development | 82.87 | 107.22 | 101 | 67.08 | 56.99 | 45.49 | |
| Operating Expenses | 112.64 | 136.1 | 127.06 | 87.32 | 73.02 | 58.26 | |
| Operating Income | -112.64 | -136.1 | -127.06 | -85.8 | -69.21 | -53.21 | |
| Other Non Operating Income (Expenses) | 4.2 | 3.42 | 4.53 | 1.66 | 1.28 | 1.81 | |
| EBT Excluding Unusual Items | -108.44 | -132.68 | -122.53 | -84.13 | -67.93 | -51.41 | |
| Gain (Loss) on Sale of Investments | 2.8 | 2.81 | 5.74 | 0.3 | -1.27 | -0.5 | |
| Pretax Income | -105.64 | -129.87 | -116.8 | -83.84 | -69.2 | -51.9 | |
| Income Tax Expense | - | - | - | - | - | 0.99 | |
| Net Income | -105.64 | -129.87 | -116.8 | -83.84 | -69.2 | -52.89 | |
| Net Income to Common | -105.64 | -129.87 | -116.8 | -83.84 | -69.2 | -52.89 | |
| Shares Outstanding (Basic) | 22 | 5 | 5 | 4 | 3 | 3 | |
| Shares Outstanding (Diluted) | 22 | 5 | 5 | 4 | 3 | 3 | |
| Shares Change (YoY) | 347.95% | 6.32% | 17.82% | 18.80% | 13.49% | 455.27% | |
| EPS (Basic) | -4.88 | -25.49 | -24.37 | -20.61 | -20.21 | -17.53 | |
| EPS (Diluted) | -4.88 | -25.49 | -24.37 | -20.61 | -20.21 | -17.53 | |
| Free Cash Flow | -86.66 | -83.42 | -98.17 | -71.62 | -61.78 | -40.89 | |
| Free Cash Flow Per Share | -4.00 | -16.37 | -20.49 | -17.61 | -18.05 | -13.55 | |
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% | |
| Operating Margin | - | - | - | -5618.53% | -1815.08% | -1055.41% | |
| Profit Margin | - | - | - | -5490.37% | -1814.95% | -1049.03% | |
| Free Cash Flow Margin | - | - | - | -4689.98% | -1620.27% | -810.97% | |
| EBITDA | -111.66 | -134.9 | -125.85 | -84.75 | -68.21 | -52.09 | |
| D&A For EBITDA | 0.97 | 1.2 | 1.22 | 1.05 | 1 | 1.12 | |
| EBIT | -112.64 | -136.1 | -127.06 | -85.8 | -69.21 | -53.21 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.